[Form 4] Vicarious Surgical Inc. Insider Trading Activity

Rhea-AI Filing Summary

Clark Randolph, identified as a director of Vicarious Surgical Inc. (RBOT), reported an acquisition on Form 4 dated 06/27/2025. The filing shows an acquisition of 8,003 stock options with an exercise (conversion) price of $7.61. The options are exercisable into 8,003 shares of Class A common stock and are reported as direct ownership following the transaction.

The filing states all shares underlying the option will vest on June 27, 2026 (or one day prior to the issuer's next annual meeting), subject to continued service, and lists an associated date of 06/26/2035 in the exercisable/expiration field. The form was signed by an attorney-in-fact on 08/11/2025.

Positive

• Director reported acquisition of 8,003 stock options, providing clear disclosure of insider ownership change
• Vesting schedule specified: options vest on 06/27/2026 (or one day prior to next annual meeting), clarifying timing of potential share issuance

Negative

• None.

Insights

Securities Analyst

TL;DR: Director Clark Randolph received 8,003 options at a $7.61 exercise price, vesting by 06/27/2026, reported on Form 4.

The Form 4 documents a routine equity award transaction: an acquisition (code "A") of 8,003 stock options exercisable into Class A common stock with an exercise price of $7.61. The options are reported as directly owned and fully vest on a specified date in mid-2026 subject to service. The filing provides clear vesting, exercise and expiration dates but does not disclose market context or aggregate holdings beyond this line. Impact on capitalization or dilution is not stated in the filing.

Corporate Governance Expert

TL;DR: This Form 4 reports a director equity grant with explicit vesting conditions and a long listed expiration date.

The disclosure identifies the reporting person as a director and records a direct acquisition of 8,003 options. The filing includes a specific vesting schedule (vesting by June 27, 2026, or one day before the next annual meeting) and a date shown as 06/26/2035 in the exercisable/expiration field, which frames the award's timeline. The signature by an attorney-in-fact is dated 08/11/2025. The filing is procedural and provides the necessary regulatory disclosure for insider ownership changes without additional governance commentary.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Clark Randolph A.

(Last) (First) (Middle)

C/O VICARIOUS SURGICAL INC.

78 FOURTH AVENUE

(Street)

WALTHAM MA 02451

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vicarious Surgical Inc. [ RBOT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$7.61	06/27/2025		A		8,003		(1)	06/26/2035	Class A Common Stock	8,003	$0.00	8,003	D

Explanation of Responses:

1. All of the shares underlying this option will vest on June 27, 2026, or one day prior to the Issuer's next Annual Meeting of Shareholders, whichever is earlier, subject to the Reporting Person's continued service through the applicable vesting date.

	/s/ Erin Checka, Attorney-in-Fact	08/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Clark Randolph report on Form 4 for RBOT?

The Form 4 reports an acquisition of 8,003 stock options on 06/27/2025 that are exercisable into Class A common stock.

What is the exercise price of the options reported for RBOT?

The options have an exercise (conversion) price of $7.61 as shown on the Form 4.

When do the reported options vest?

All shares underlying the option will vest on June 27, 2026, or one day prior to the issuer's next annual meeting, subject to continued service.

How many shares will the options convert into and what is the ownership form?

The options are exercisable into 8,003 shares of Class A common stock and are reported as direct ownership following the transaction.

What expiration or exercisable date is shown on the Form 4?

The form lists a date of 06/26/2035 in the exercisable/expiration field associated with the options.

Who signed the Form 4 and when?

The Form 4 was signed by Erin Checka, Attorney-in-Fact on 08/11/2025.